Acacia raises series A to advance cancer care pipeline
This article was originally published in Scrip
Executive Summary
Acacia Pharma of the UK has raised $10 million in a series A round that will fund two lead programmes to the end of Phase II. New investor Lundbeckfond Ventures joined seed investor Gilde Healthcare in the financing.